Details of the Active Pharmaceutical Ingredient (API)
General Information of API (ID: D00675) | |||||
---|---|---|---|---|---|
Name |
Ticlopidine
|
||||
Synonyms |
Click to Show/Hide the Synonyms of This API
ticlopidine; 55142-85-3; 5-(2-Chlorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine; Ticlid; Ticlopidinum; Ticlopidina; PCR 5332; UNII-OM90ZUW7M1; 5-[(2-chlorophenyl)methyl]-6,7-dihydro-4H-thieno[3,2-c]pyridine; 5-[(2-chlorophenyl)methyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridine; 5-((2-Chlorophenyl)methyl)-4,5,6,7-tetrahydrothieno(3,2-c)pyridine; OM90ZUW7M1; CHEBI:9588; 5-[(2-chlorophenyl)methyl]-4H,5H,6H,7H-thieno[3,2-c]pyridine; Ticlopidine-d4; Thieno(3,2-c)pyridine, 4,5,6,7-tetrahydro-5-((2-chlorophenyl)methyl)-; PCR 5332; Ticlid; Ticlop;Tiklyd; NCGC00016872-06; DSSTox_CID_3669; Thieno[3,2-c]pyridine, 5-[(2-chlorophenyl)methyl]-4,5,6,7-tetrahydro-; Ticlopidine [INN:BAN]; DSSTox_RID_77136; DSSTox_GSID_23669; Ticlopidinum [INN-Latin]; Ticlopidina [INN-Spanish]; Thieno(3,2-c)pyridine, 5-((2-chlorophenyl)methyl)-4,5,6,7-tetrahydro-; SMR000641861; Ticlopidine (INN); CAS-55142-85-3; Ticlopidin-Puren (TN); EINECS 259-498-5; BRN 1216802; 1246817-49-1; Thieno[3,2-c]pyridine, 5-[(2-chlorophenyl)methyl]-4,5,6,7-tetrahydro-, hydrochloride; Prestwick0_000047; Prestwick1_000047; Prestwick2_000047; Prestwick3_000047; CHEMBL833; SCHEMBL4204; BIDD:PXR0169; BSPBio_000173; MLS001201825; MLS006011439; SPBio_002094; BPBio1_000191; GTPL7307; DTXSID5023669; BDBM85509; HMS2089I18; HMS2962E14; BCP25528; NSC_5472; Tox21_110658; BBL028843; MFCD00661081; STK589340; ZINC19594599; AKOS005511613; Tox21_110658_1; DB00208; DS-6623; MCULE-3971692083; NCGC00016872-01; NCGC00016872-02; NCGC00016872-03; NCGC00016872-04; NCGC00016872-05; NCGC00016872-07; NCGC00016872-09; NCGC00016872-10; NCGC00016872-12; NCGC00024361-04; AC-15204; AK122369; SBI-0206813.P001; CAS-53885-35-1; CAS_55142-85-3; UNM-0000345023; FT-0619727; FT-0675227; ST51015152; C07140; D08594; 142T853; L001108; Q420571; BRD-K00603606-003-03-4; BRD-K00603606-003-13-3; Z231745614; 5-(2-chlorobenzyl)-6,7-dihydro-4H-thieno[3,2-c]pyridine; 5-(2-chlorobenzyl)-4,5,6,7tetrahydrothieno[3,2-c]pyridine; 5-(O-Chlorobenzyl)-4,5,6,7-tetrahydrothieno-[3,2-c]pyridine; 5-(2-Chlorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine #; 5-[(2-chlorophenyl)methyl]-4,5,6,7-tetrahydrothiopheno[3,2-c]pyridine
|
||||
Clinical Status |
Approved
|
||||
Disease Indication | Cerebral stroke | ICD-11: 8B11 | [1] | ||
PubChem CID | |||||
Formula |
C14H14ClNS
|
||||
Canonical SMILES |
C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
|
||||
InChI |
1S/C14H14ClNS/c15-13-4-2-1-3-11(13)9-16-7-5-14-12(10-16)6-8-17-14/h1-4,6,8H,5,7,9-10H2
|
||||
InChIKey |
PHWBOXQYWZNQIN-UHFFFAOYSA-N
|
||||
Click to Show/Hide the Molecular Data (Structure/Property) of This API | |||||
Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=5472"></iframe>
|
||||
3D MOL | 2D MOL | ||||
Physicochemical Properties | Molecular Weight | 263.8 | Topological Polar Surface Area | 31.5 | |
XlogP | 3.6 | Complexity | 261 | ||
Heavy Atom Count | 17 | Rotatable Bond Count | 2 | ||
Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 2 | ||
Full List of Drug Formulations (DFMs) Containing This API | ||||||
---|---|---|---|---|---|---|
Ticlopidine 250 mg tablet | Click to Show/Hide the Full List of Formulation(s): 5 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Magnesium stearate; Butylated hydroxyanisole; Titanium dioxide; Povidone; Cellulose, microcrystalline; Hypromelloses; Polyethylene glycols; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | AvKARE; Teva Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [2] | |||
Butylhydroxyanisole | DIG Info | Prostaglandin G/H synthase 2 (IC50 = 2.6 uM) | [2] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [3] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Magnesium stearate; Butylated hydroxyanisole; Titanium dioxide; Cellulose, microcrystalline; Hypromelloses; Polyethylene glycols; Povidones; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Carilion Materials Management | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [2] | |||
Butylhydroxyanisole | DIG Info | Prostaglandin G/H synthase 2 (IC50 = 2.6 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Titanium dioxide; Croscarmellose sodium; Cellulose, microcrystalline; Hypromellose 2910 (5 mpa.s); Polyethylene glycol
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Apotex | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [2] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [4] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Titanium dioxide; Polysorbate 80; Povidone; Cellulose, microcrystalline; Colloidal silicon dioxide; Hypromelloses; Polyethylene glycol; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Eon Labs | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Polysorbate 80 | DIG Info | Prostaglandin G/H synthase 1 (IC50 = 1 uM) | [2] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [3] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Talc; Titanium dioxide; Polyethylene glycol 400; Polysorbate 80; Cellulose, microcrystalline; Hypromelloses; Polyethylene glycols; Starch, pregelatinized corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Caraco Pharmaceutical Laboratories | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Polysorbate 80 | DIG Info | Prostaglandin G/H synthase 1 (IC50 = 1 uM) | [2] | |||
Polyethylene glycol 400 | DIG Info | Albendazole monooxygenase (IC50 = 10.77 mg.mL-1) | [5] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.